Nano, Mark Drakeaxel Rreign L.

HRN: 23-72-43  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2023
AMPICILLIN 500MG (VIAL)
09/21/2023
09/28/2023
IV
260mg
Q12
UTI
09/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/21/2023
09/28/2023
IV
80mg
Q24
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: